Related references
Note: Only part of the references are listed.Discovery of G Protein-Biased Ligands against 5-HT7R
Jieon Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
Jieon Lee et al.
MOLECULES (2021)
G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism
Jon DelaCuesta-Barrutia et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D. McCorvy et al.
NATURE CHEMICAL BIOLOGY (2018)
Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update
Maria N. Modica et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of β-Arrestin Biased Ligands of 5-HT7R
Youngjae Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram et al.
MOLECULAR PHARMACOLOGY (2018)
Biased signalling: from simple switches to allosteric microprocessors
Jeffrey S. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
New Insights into Modes of GPCR Activation
Wenjing Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology
Zuzana Bologna et al.
BIOMOLECULES & THERAPEUTICS (2017)
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker et al.
CELL (2017)
Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects
Yang Zhou et al.
NEURON (2016)
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models
Clinton E. Canal et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1
Omella Manfra et al.
ACS CHEMICAL NEUROSCIENCE (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis
Stefano Gabriele et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome
Bianca De Filippis et al.
NEUROPSYCHOPHARMACOLOGY (2014)
5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders
Lucia Ciranna et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
A Real-Time Method for Measuring cAMP Production Modulated by Gαi/o-Coupled Metabotropic Glutamate Receptors
John O. DiRaddo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Serotonin Hypothesis of Autism: Implications for Selective Serotonin Reuptake Inhibitor Use during Pregnancy
Rebecca A. Harrington et al.
AUTISM RESEARCH (2013)
Aryl Biphenyl-3-ylmethylpiperazines as 5-HT7 Receptor Antagonists
Jeeyeon Kim et al.
CHEMMEDCHEM (2013)
Binding Modes of Chain Arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 Receptors
Anna Bielenica et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
Agnieszka Nikiforuk et al.
PLOS ONE (2013)
Structural Basis for Molecular Recognition at Serotonin Receptors
Chong Wang et al.
SCIENCE (2013)
Structural Features for Functional Selectivity at Serotonin Receptors
Daniel Wacker et al.
SCIENCE (2013)
Antagonist interaction with the human 5-HT7 receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect
M. T. Klein et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives
Anne Matthys et al.
MOLECULAR NEUROBIOLOGY (2011)
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Joao Peca et al.
NATURE (2011)
FETAL, MATERNAL, AND PLACENTAL SOURCES OF SEROTONIN AND NEW IMPLICATIONS FOR DEVELOPMENTAL PROGRAMMING OF THE BRAIN
A. Bonnin et al.
NEUROSCIENCE (2011)
Discovery of β-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
John A. Allen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Serotonin, pregnancy and increased autism prevalence: Is there a link?
Nouchine Hadjikhani
MEDICAL HYPOTHESES (2010)
The Expanded Biology of Serotonin
Miles Berger et al.
ANNUAL REVIEW OF MEDICINE (2009)
Sustained Neurobehavioral Effects of Exposure to SSRI Antidepressants During Development: Molecular to Clinical Evidence
T. F. Oberlander et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Dopamine and serotonin levels following prenatal viral infection in mouse - Implications for psychiatric disorders such as schizophrenia and autism
Christine Winter et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
The genetic design of signaling cascades to record receptor activation
Gilad Barnea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder
Peter B. Hedlund et al.
NEUROSCIENCE LETTERS (2007)
β-arrestin signaling and regulation of transcription
Lan Ma et al.
JOURNAL OF CELL SCIENCE (2007)
5-HT7 receptor ligands: Recent developments and potential therapeutic applications
Valeria Pittala et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
Receptor-based pharmacophores for serotonin 5-HT7R antagonists -: Implications to selectivity
Marcin Kolaczkowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
GRKs and β-arrestins:: roles in receptor silencing, trafficking and signaling
Eric Reiter et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
The repertoire of G-protein-coupled receptors in fully sequenced genomes
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2005)
Optimization of the pharmacophore model for 5-HT7R antagonism.: Design and synthesis of new naphtholactam and naphthosultam derivatives
ML López-Rodríguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Characterization of the 5-HT7 receptor.: Determination of the pharmacophore for 5-HT7 receptor agonism and CoMFA-based modeling of the agonist binding site
ES Vermeulen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
G protein-coupled receptors in drug discovery
P Nambi et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2003)
Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions
R Yuan et al.
DRUG METABOLISM AND DISPOSITION (2002)
Altered synaptic plasticity in a mouse model of fragile X mental retardation
KM Huber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist
JJ Hagan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
A novel, potent, and selective 5-HT7 antagonist:: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)
PJ Lovell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)